Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Early research (Phase 1)Looking for participantsNCT06393738What this trial is testingARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Who this might be right forRelapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL) Arvinas Inc. 329
Early research (Phase 1)Study completedNCT02576496What this trial is testingStudy of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic MalignanciesWho this might be right forHematological MalignanciesMultiple MyelomaHodgkin's Lymphoma+1 more Mundipharma Research Limited 106
Testing effectiveness (Phase 2)Study completedNCT02424045What this trial is testingBendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell LymphomaWho this might be right forT-cell Lymphoma Samsung Medical Center 30
Not applicableUnknownNCT05821192What this trial is testingChemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.Who this might be right forPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma Ou Bai, MD/PHD 34
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Early research (Phase 1)Study completedNCT00002980What this trial is testingDecitabine in Treating Patients With Melanoma or Other Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more California Cancer Consortium
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT05627856What this trial is testingGNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHLWho this might be right forNK/T Cell LymphomaVascular Immunomother T Cell LymphomaNon-Hodgkin Lymphoma Sichuan Baili Pharmaceutical Co., Ltd. 4
Testing effectiveness (Phase 2)UnknownNCT05527275What this trial is testingA Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell LymphomaWho this might be right forRelapsed and Refractory Peripheral T-cell Lymphoma Sun Yat-sen University 78
Large-scale testing (Phase 3)Study completedNCT03703375What this trial is testingEfficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell LymphomaWho this might be right forLymphoma, T-Cell Celgene 93
Testing effectiveness (Phase 2)UnknownNCT04457830What this trial is testingThe Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).Who this might be right forPeripheral T Cell Lymphoma Shandong New Time Pharmaceutical Co., LTD 105
Very early researchUnknownNCT04696705What this trial is testingAllogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) PatientsWho this might be right forNon-Hodgkin's Lymphoma (NHL)Peripheral T Cell Lymphoma (PTCL) Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableStudy completedNCT06113081What this trial is testingReal World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell LymphomaWho this might be right forCutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome Fondazione Italiana Linfomi - ETS 100
Testing effectiveness (Phase 2)Ended earlyNCT05105412What this trial is testingLenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell LymphomasWho this might be right forPeripheral T-cell Lymphomas (PTCL) National Health Research Institutes, Taiwan 12
Very early researchUnknownNCT05208853What this trial is testingAn Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory LymphomaWho this might be right forHodgkin LymphomaNK/T Cell LymphomaPeripheral T Cell Lymphoma, Unspecified+5 more Zhejiang University 9
Early research (Phase 1)Study completedNCT01614197What this trial is testingA Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins LymphomaWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LymphomaPeripheral T-cell Lymphoma Therapeutic Advances in Childhood Leukemia Consortium 16
Testing effectiveness (Phase 2)Study completedNCT03496779What this trial is testingStudy of Brentuximab Vedotin in Patients With R/R PTCL Treated With GemcitabineWho this might be right forRefractory Peripheral T-Cell LymphomaRelapsed Peripheral T-Cell Lymphoma The Lymphoma Academic Research Organisation 71
Testing effectiveness (Phase 2)Ended earlyNCT01998035What this trial is testingRomidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid MalignanciesWho this might be right forLymphoid MalignanciesLymphomaHodgkin Lymphoma+1 more Columbia University 58